JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32085

Anti-Progesterone Receptor antibody [YR85]

4

(5 Reviews)

|

(49 Publications)

Anti-Progesterone Receptor antibody [YR85] (ab32085) is a rabbit monoclonal antibody detecting Progesterone Receptor in Western Blot, Flow Cytometry (Intra), IP, IHC-P, ICC/IF. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
- Trusted since 2006

View Alternative Names

NR3C3, PGR, Progesterone receptor, PR, Nuclear receptor subfamily 3 group C member 3

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] (AB32085)

Immunofluorescence staining of Recombinant Anti-Progesterone Receptor antibody [YR85] (ab32085) in T47D cells (+ve control) and HepG2 cells (-ve control). The cells were fixed with 4% paraformaldehyde (10 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab32085 at 0.2 μg/mL dilution and ab7291, Anti-alpha Tubulin antibody [DM1A], at 1/1000 dilution, followed by a further incubation at room temperature for 1h with Goat Anti-Rabbit IgG H&L (Alexa Fluor® 647) preadsorbed (ab150087) at 1/1000 (shown in red) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (ab150117) at 1/1000 (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with the Perkin Elmer Operetta and a maximum intensity projection of confocal planes is shown.

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] (AB32085)

Immunofluorescence staining of Recombinant Anti-Progesterone Receptor antibody [YR85] (ab32085) in T47D cells (+ve control) and HepG2 cells (-ve control). The cells were fixed with 100% Methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at +4°C with ab32085 at 0.2 μg/mL dilution and ab7291, Anti-alpha Tubulin antibody [DM1A], at 1/1000 dilution, followed by a further incubation at room temperature for 1h with Goat Anti-Rabbit IgG H&L (Alexa Fluor® 647) preadsorbed (ab150087) at 1/1000 (shown in red) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) preadsorbed (ab150117) at 1/1000 (shown in green). Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with the Perkin Elmer Operetta and a maximum intensity projection of confocal planes is shown.

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [YR85] (AB32085)

ICC/IF image of ab32085 stained DU145 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab32085 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [YR85] (AB32085)

Immunohistochemical analysis of progesterone receptor expression in paraffin embedded human breast carcinoma, using 1/100 ab32085.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Flow Cytometry (Intracellular) - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Progesterone Receptor antibody [YR85] (AB32085)

Intracellular Flow Cytometry analysis of T47D (human mammary gland ductal carcinoma) cells labeling Progesterone Receptor with purified ab32085 at 1/1100 dilution (1ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) (ab150077) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) (ab172730) was used as the isotype control, Cell without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

Western blot - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • WB

Unknown

Western blot - Anti-Progesterone Receptor antibody [YR85] (AB32085)

Blocking buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Progesterone Receptor antibody [YR85] (ab32085) at 1/2000 dilution

All lanes:

T-47D (Human ductal breast epithelial tumor epithelial cell) whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 98 kDa

Observed band size: 118 kDa

false

Exposure time: 40s

Western blot - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • WB

Unknown

Western blot - Anti-Progesterone Receptor antibody [YR85] (AB32085)

All lanes:

Western blot - Anti-Progesterone Receptor antibody [YR85] (ab32085) at 1/1000 dilution

All lanes:

Human breast cancer lysate at 15 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/20000 dilution

Predicted band size: 98 kDa

Observed band size: 118 kDa

false

Exposure time: 180s

OI-RD Scanning - Anti-Progesterone Receptor antibody [YR85] (AB32085)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-Progesterone Receptor antibody [YR85] (AB32085)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Carrier free

    Anti-Progesterone Receptor antibody [YR85] - BSA and Azide free

  • 578 PE

    PE Anti-Progesterone Receptor antibody [YR85]

  • HRP

    HRP Anti-Progesterone Receptor antibody [YR85]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Progesterone Receptor antibody [YR85]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Progesterone Receptor antibody [YR85]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-Progesterone Receptor antibody [YR85]

  • 660 APC

    APC Anti-Progesterone Receptor antibody [YR85]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Progesterone Receptor antibody [YR85]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Progesterone Receptor antibody [YR85]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

YR85

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IP, ICC/IF, Flow Cyt (Intra), WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody recognises progesterone receptor. The antibody does not cross-react with other NR3 family members. Since the recognized epitope is near the N-terminal end of the protein, this product should only detect isoform B and not isoform A.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "guaranteed", "IP-species-dilution-info": "1/150", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "0.2-5 µg/mL", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-Progesterone Receptor antibody [YR85] (ab32085) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of Progesterone Receptor?
Anti-Progesterone Receptor [YR85] (ab32085) specifically detects a band for Progesterone Receptor (UniProt: P06401) at a molecular weight of 99kDa.

Trusted by the scientific community
Anti-Progesterone Receptor [YR85] (ab32085) was first used in a scientific publication in 2006 and has been cited over 30 times in peer-reviewed journals.

Reviewed by scientists
Anti-Progesterone Receptor [YR85] (ab32085) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [YR85] also available for your convenience: ab32085, Carrier free - ab206926, PE - ab303062, APC - ab303063, HRP - ab303064, Alkaline Phosphatase - ab308712, Alexa Fluor® 647 - ab310043, Alexa Fluor® 594 - ab310431, Alexa Fluor® 555 - ab311957, Alexa Fluor® 568 - ab312430, Alexa Fluor® 488 - ab313737

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The progesterone receptor (PR) also known as NR3C3 is a nuclear receptor that functions as a transcription factor in response to the hormone progesterone. This receptor has a mass of approximately 99 kDa and is expressed in tissues such as the reproductive organs including the uterus ovaries and mammary glands. It is also found in non-reproductive tissues like the brain and bone. The receptor has two main isoforms PR-A and PR-B which differ slightly in structure but have unique biological roles.
Biological function summary

The progesterone receptor plays a significant role in regulating gene expression related to reproductive processes. PR is not part of a larger complex by itself but interacts with various coactivators and corepressors to modulate transcription. In the uterus and mammary glands PR mediates the effects of progesterone by promoting cell proliferation and preparing tissues for pregnancy. In other systems PR also links to various metabolic and immunological pathways influencing cell cycle progression and immune response.

Pathways

Progesterone receptor activity is integrated within the reproductive hormone signaling pathways and the Wnt signaling pathway. The receptor interacts directly with key proteins such as estrogen receptor (ER) and steroid receptor coactivator (SRC) complexes which are pivotal in modulating response to hormonal signals. These interactions underline the essential role of PR in maintaining hormonal balance and regulating reproductive functions.

The progesterone receptor associates with breast cancer and endometriosis. Aberrant expression or mutations in PR can contribute to the development and progression of breast cancer often linked with the estrogen receptor's influence. In endometriosis PR's altered functionality affects cellular response to progesterone contributing to tissue growth outside the uterus. These conditions also involve interactions with proteins like BRCA1 in breast cancer highlighting how PR connects to broader cellular and pathological networks.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Depending on the isoform, progesterone receptor functions as a transcriptional activator or repressor.. Isoform A. Ligand-dependent transdominant repressor of steroid hormone receptor transcriptional activity including repression of its isoform B, MR and ER. Transrepressional activity may involve recruitment of corepressor NCOR2.. Isoform B. Transcriptional activator of several progesteron-dependent promoters in a variety of cell types. Involved in activation of SRC-dependent MAPK signaling on hormone stimulation.. Isoform 4. Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
See full target information PGR

Publications (49)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular sciences 26: PubMed40362654

2025

Topological Distribution of the Sex Hormone Receptor Expressions Highlights the Importance of Stromal ERα and Epithelial PR in Malignant Transformation of the Uterine Cervix.

Applications

Unspecified application

Species

Unspecified reactive species

Mun-Kun Hong,Jen-Hung Wang,Ming-Hsun Li,Cheng-Chuan Su,Chiu-Hsuan Cheng,Tang-Yuan Chu

Oncogene 44:2240-2252 PubMed40221530

2025

Loss of LATS1 and LATS2 promotes ovarian tumor formation by enhancing AKT activity and PD-L1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Yalun Zhu,Atefeh Abedini,Galaxia M Rodriguez,Curtis W McCloskey,John Abou-Hamad,Omar Salah Salah,Janie Larocque,Mayra F Tsoi,Derek Boerboom,David Cook,Barbara Vanderhyden

Scientific reports 15:8852 PubMed40087289

2025

Dynamic culture system advances the applications of breast cancer organoids for precision medicine.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Yang,Junyuan Qu,Mei Zhang,Xiang Li,Qian Jiang,Jinxiu Kang,Pan Nie,Na Jing,Xianling Wang

Nature medicine 31:502-513 PubMed39775038

2025

Multi-omics-based mapping of decidualization resistance in patients with a history of severe preeclampsia.

Applications

Unspecified application

Species

Unspecified reactive species

Irene Muñoz-Blat,Raúl Pérez-Moraga,Nerea Castillo-Marco,Teresa Cordero,Ana Ochando,Sheila Ortega-Sanchís,Marcos Parras-Moltó,Rogelio Monfort-Ortiz,Elena Satorres-Perez,Blanca Novillo,Alfredo Perales,Matthew Gormley,Sofia Granados-Aparici,Rosa Noguera,Beatriz Roson,Susan J Fisher,Carlos Simón,Tamara Garrido-Gómez

Heliyon 10:e38720 PubMed39640749

2024

NCLN as a potential prognosis biomarker in endometrial cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Huang-Jin Luo,Li-Tong Zhu,Yu Dai,Yun Ma,Kai Wang,Lei Zhang,Qiu-Xia Li,Ping Jin

Human reproduction (Oxford, England) 40:119-137 PubMed39521729

2024

Upregulated let-7 expression in the follicular fluid of patients with endometriomas leads to dysfunction of granulosa cells through targeting of IGF1R.

Applications

Unspecified application

Species

Unspecified reactive species

Libing Shi,Hanqi Ying,Yongdong Dai,Yan Rong,Jianmin Chen,Feng Zhou,Shasha Wang,Shiqian Xu,Xiaomei Tong,Songying Zhang

Current issues in molecular biology 46:9376-9385 PubMed39329907

2024

Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor.

Applications

Unspecified application

Species

Unspecified reactive species

Kosuke Kanno,Kentaro Nakayama,Sultana Razia,Sohel Hasibul Islam,Zahan Umme Farzana,Shahataj Begum Sonia,Hiroki Sasamori,Hitomi Yamashita,Tomoka Ishibashi,Masako Ishikawa,Kayo Imamura,Noriyoshi Ishikawa,Satoru Kyo

Oncology letters 28:451 PubMed39100992

2024

Newer combination treatments for breast cancer coexisting with acute myeloid leukemia in the novel regimens era: A case report and literature review.

Applications

Unspecified application

Species

Unspecified reactive species

Lina Xing,Tian Tian,Yang Li,Jingnan Zhang,Xiaonan Guo,Shukai Qiao

Scientific reports 14:14177 PubMed38898061

2024

Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts.

Applications

Unspecified application

Species

Unspecified reactive species

Lisa Nocquet,Julie Roul,Chloé C Lefebvre,Laurine Duarte,Mario Campone,Philippe P Juin,Frédérique Souazé

Nature communications 15:945 PubMed38296945

2024

Effect of aging on the human myometrium at single-cell resolution.

Applications

Unspecified application

Species

Unspecified reactive species

Paula Punzon-Jimenez,Alba Machado-Lopez,Raul Perez-Moraga,Jaime Llera-Oyola,Daniela Grases,Marta Galvez-Viedma,Mustafa Sibai,Elena Satorres-Perez,Susana Lopez-Agullo,Rafael Badenes,Carolina Ferrer-Gomez,Eduard Porta-Pardo,Beatriz Roson,Carlos Simon,Aymara Mas
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com